אבוסינאגיס 50 מ"ג

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

PALIVIZUMAB 50 MG

可用日期:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

ATC代码:

J06BB16

药物剂型:

POWDER FOR SOLUTION FOR INJECTION

给药途径:

I.M

厂商:

ABBVIE S.R.L., ITALY

治疗组:

PALIVIZUMAB

疗效迹象:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

授权日期:

2010-07-01